About Behshad Sheldon
Behshad Sheldon is a director at Maxona Pharmaceuticals.
Behshad Sheldon first appears on SEC filings in 2021.
Experience
This experience comes from Behshad Sheldon's profile and from SEC filings. For roles taken from filings, the years are when the filings name Behshad Sheldon in the role, so the role may have started earlier or lasted longer.
Maxona Pharmaceuticals, Inc. Current
Member Board of Directors
2021 – Present · Malvern, PA
Develops oral pain medicines for people with acute and chronic pain.
CA
Camurus Current
President, Camurus Inc
2018 – Present
FE
FORCE (Female Opioid Research & Clinical Experts) Current
Chair Board of Directors
2017 – Present
BA
Biotech Value Advisors
EVP & Managing Director
2020 – 2024
RU
R-Pharm US
Chief Commercial Officer & Head of Development
2017 – 2019
BP
Braeburn Pharmaceuticals
President & Chief Executive Officer
2012 – 2017
CI
Cerecor Inc.
Director on Board
2014 – 2016
AP
AppleTree Partners
Venture Partner
2013 – 2016
OP
Otsuka Pharmaceuticals
SVP, Patient & Branding Strategy (aka Commercial Lead)
2009 – 2012
OI
Otsuka Pharmaceutical Development & Commercialization, Inc
Board of Directors Member (2006 – 2012)
VP, Abilify, Princeton Aripiprazole Unit (PAU) (2002 – 2006)
2002 – 2012
BS
Bristol-Myers Squibb
Senior Director, US Plavix Brand Lead
1996 – 2000
SB
SmithKline Beecham
Progressive responsibility
1986 – 1996
Key Colleagues at Startups
The people Behshad Sheldon works with at each company, as listed on that company's latest Form D.
Maxona Pharmaceuticals, Inc. · Form D/A, Aug 14, 2026
Richard Brand
Chief Financial Officer
SF
Shahin Fatholahi
Chief Executive Officer and director
DN
David Nakamura
Director